Clinical trial
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2001
- Completion date
- Not reported
- Enrollment
- 300
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
orthostatic hypotension